Skip to content

Evaluation of expanded digitized imaging in VR and AR for cholangiocarcinoma

Evaluation of expanded digitized imaging in VR and AR for cholangiocarcinoma - Eva-diBi

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022399
Enrollment
5
Registered
2020-07-30
Start date
2020-07-06
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.1

Interventions

Group 1: Before surgery: (1-2 days before the operation) Based on a checklist and an example, the developer explains all functions of VR-Tool for OP- planning tool
surgeon testing the VR-Tool and using the "Think-Aloud Method". In addition the surgeon will be observe during testing. Semi-structured individual interviews will conducted after testing the VR-Tool,
During the operation: Use of AR-Tool by surgeons, film the use during the operation
After operation: semi-structured interview with the medical team regarding VR / AR application.

Sponsors

Pius-HospitalMedizinischer Campus Universität Oldenburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Surgeons: • All surgoens involved in the operational planning and the operation itselfi • For pretest: Surgeons outside of the core team but the knowledge of the case Patient: • Patient with cholangiocarcinoma

Exclusion criteria

Exclusion criteria: Surgeons: · Refusal to participate in the study Patient: · Refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Usefulness of the new VR and AR methods for the surgeons preoperational planning and during the operation.

Secondary

MeasureTime frame
Usability of the new systems.

Countries

Germany

Contacts

Public ContactDaniela Salzmann

Universitätsklinik für ViszeralchirurgieUniversitätsmedizin Oldenburg, Pius-Hospital Oldenburg

daniela.salzmann@uol.de0441-2291991

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026